On oral contraceptive safety: cardiovascular problems
Edgren, R.A.
International Journal of Fertility 26(4): 241-244
1981
ISSN/ISBN: 0020-725X PMID: 6120903 Document Number: 182550
Document emailed within 1 workday
Related Documents
Samy Suissa; Brenda Hemmelgarn; Walter, O. Spitzer; James Brophy; Jean-Paul Collet; Robert Cǒte; Winanne Downey; Lindsay Edouard; Jacques Leclerc; Ora Paltiel 1993: The Saskatchewan oral contraceptive cohort study of oral contraceptive use and cardiovascular risks Pharmacoepidemiology and Drug Safety 2(1): 33-49Murty, J.; Firth, S. 1996: Effect of CSM's warning about safety of third generation oral contraceptives. Contraceptive effectiveness may be being sacrificed for safety Bmj 313(7053): 363
Radowicki, S.ła.; Skórzewska, K.; Szlendak, K. 2005: Safety evaluation of a transdermal contraceptive system with an oral contraceptive Ginekologia Polska 76(11): 884-889
Radowicki, S.ła.; Skórzewska, K.; Szlendak, K. 2005: Safety evaluation of a transdermal contraceptive system with an oral contraceptive Ginekologia Polska 76(11): 884-889
Surampudi, P.; Page, S.T.; Swerdloff, R.S.; Nya-Ngatchou, J.J.; Liu, P.Y.; Amory, J.K.; Leung, A.; Hull, L.; Blithe, D.L.; Woo, J.; Bremner, W.J.; Wang, C. 2014: Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dimethandrolone undecanoate in man: a prototype oral male hormonal contraceptive Andrology 2(4): 579-587
Sturtevant, F.M. 1991: Cardiovascular safety of oral contraceptives: a critical commentary International Journal of Fertility 36(Suppl 3): 32-36
Shulman, L.P. 2002: Safety and efficacy of a new oral contraceptive containing drospirenone Journal of Reproductive Medicine 47(11 Suppl): 981-984
Potts, M.; Denny, C. 1995: Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status Drug Safety 13(6): 333-337
Al-Shaikh, G.K.; Mayet, A.Y.; Alshaikh, M.K.; Hamad, A.F.; Mahmoud, M.A.; Aljadhey, H.S. 2012: Knowledge on adherence and safety of the oral contraceptive pill in Saudi women Saudi Medical Journal 33(6): 665-670
Fehr, A.D.; Mounsey, A.; Yates, J.E.; Flake, D. 2012: FPIN's clinical inquiries. Cardiovascular risk of combined oral contraceptive use American Family Physician 86(12): 1-2
Caiyan, W.; Wen, D.; Qinping, L.; Huan, S.; Ziyan, H.; Liangdan, T.; Zheng'ai, X.; Yufeng, L.; Shulan, Z.; Baihua, D.; Xiaoyan, X.; Mulan, R.; Xiaomao, L.; Youdi, X.; Zhisong, M.; Meiqing, X.; Hongyu, W.; Zirong, H. 2014: Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in a 24+4-day regimen in China Zhonghua Fu Chan Ke Za Zhi 49(5): 355-359
Caiyan, W.; Wen, D.; Qinping, L.; Huan, S.; Ziyan, H.; Liangdan, T.; Zheng'ai, X.; Yufeng, L.; Shulan, Z.; Baihua, D.; Xiaoyan, X.; Mulan, R.; Xiaomao, L.; Youdi, X.; Zhisong, M.; Meiqing, X.; Hongyu, W.; Zirong, H. 2014: Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in a 24+4-day regimen in China Zhonghua Fu Chan Ke Za Zhi 49(5): 355-359
Darney, P. 1993: Safety and efficacy of a triphasic oral contraceptive containing desogestrel: Results of three multicenter trials Contraception 48(4): 323-337
Kroll, R.; Ackerman, R.; Feldman, R.; Howard, B.; Weiss, H.; Hsieh, J.; Ricciotti, N. 2016: Efficacy and safety of a 21/7-active combined oral contraceptive with continuous low-dose ethinyl estradiol Contraception 93(3): 249-256
LaGuardia, K.D.; Shangold, G.; Fisher, A.; Friedman, A.; Kafrissen, M. 2003: Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol Contraception 67(6): 431-437
Flint, P.M.; Lapane, K.L.; Barbour, M.M.; Derby, C.A.; Carleton, R.A.; Hume, A.L. 1995: Cardiovascular risk profiles of oral contraceptive users and nonusers: a population-based study Preventive Medicine 24(6): 586-590
Malek-Khosravi, S. 2008: Risk factors of cardiovascular disease among the oral contraceptive users in Kermanshah City of Iran Jpma. Journal of the Pakistan Medical Association 58(8): 473-474
Davis, M.C.; Matthews, K.A. 1990: Cigarette smoking and oral contraceptive use influence women's lipid, lipoprotein, and cardiovascular responses during stress Health Psychology: Official Journal of the Division of Health Psychology American Psychological Association 9(6): 717-736
Hadji, P.; Biskup, J.; Boekhoff, J.; Ziller, M.; Bonn, M.; Rovati, L. 2012: Evaluation of efficacy, safety and effects on symptoms of androgenization of a generic oral contraceptive containing chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg Contraception 86(4): 359-365
Portman, D.J.; Kaunitz, A.M.; Howard, B.; Weiss, H.; Hsieh, J.; Ricciotti, N. 2014: Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive Contraception 89(4): 299-306